PMB designs, develops and manufactures the FlashKnife radiotherapy system which delivers an ultra-high dose rate in a fraction of a second, sparing healthy tissue while effectively destroying cancer cells. The efficacy of FLASH has been shown in several preclinical studies, reproducibly, as compared to the damage caused by conventional radiotherapy.
This very short irradiation time eliminates any effect of organ or tumor movement and greatly enhances targeting precision and accuracy.
FLASHKNiFE: FLASH Radiotherapy System in the Treatment of Cancer
